{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/RANI/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T16:15:28.468Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11128,"canonical_name":"Rani Therapeutics Holdings, Inc.","cik":"0001856725","uei":null,"lei":null,"duns":null,"ticker":"RANI"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":29},"count":29,"timeline":[{"ts":"2026-09-29","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-09-29","url_slug":"/sec/cik-0001856725/4/0001193125-26-407648","accession_number":"0001193125-26-407648","importance":30},{"ts":"2026-09-29","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-09-29","url_slug":"/sec/cik-0001856725/4/0001193125-26-407684","accession_number":"0001193125-26-407684","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Rani Therapeutics Holdings, Inc. — 2026-08-13","url_slug":"/sec/cik-0001856725/10-q/0001193125-26-349245","accession_number":"0001193125-26-349245","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Rani Therapeutics Holdings, Inc. — 2026-08-13","url_slug":"/sec/cik-0001856725/8-k/0001193125-26-349197","accession_number":"0001193125-26-349197","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Rani Therapeutics Holdings, Inc. — 2026-08-04","url_slug":"/sec/cik-0001856725/8-k/0001193125-26-331594","accession_number":"0001193125-26-331594","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"3","title":"3 — Rani Therapeutics Holdings, Inc. — 2026-08-04","url_slug":"/sec/cik-0001856725/3/0001930862-26-000010","accession_number":"0001930862-26-000010","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-08-04","url_slug":"/sec/cik-0001856725/4/0001930862-26-000011","accession_number":"0001930862-26-000011","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Rani Therapeutics Holdings, Inc. — 2026-07-31","url_slug":"/sec/cik-0001856725/schedule-13g-a/0002100119-26-001443","accession_number":"0002100119-26-001443","importance":30},{"ts":"2026-07-21","kind":"sec.insider.p","reporter":"IMRAN MIR A","title":"","shares":36000,"price_per_share":0.69,"usd_value":24840,"security_title":"Class A Common Stock","importance":50.02484},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-07-21","url_slug":"/sec/cik-0001856725/4/0001869579-26-000006","accession_number":"0001869579-26-000006","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-07-21","url_slug":"/sec/cik-0001856725/4/0001869579-26-000007","accession_number":"0001869579-26-000007","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-07-21","url_slug":"/sec/cik-0001856725/4/0001871423-26-000010","accession_number":"0001871423-26-000010","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-07-21","url_slug":"/sec/cik-0001856725/4/0002123843-26-000008","accession_number":"0002123843-26-000008","importance":30},{"ts":"2026-07-17","kind":"sec.insider.p","reporter":"Imran Talat","title":"Chief Executive Officer","shares":35000,"price_per_share":0.7198,"usd_value":25193,"security_title":"Class A Common Stock","importance":50.025193},{"ts":"2026-07-15","kind":"sec.filing","form_type":"S-8","title":"S-8 — Rani Therapeutics Holdings, Inc. — 2026-07-15","url_slug":"/sec/cik-0001856725/s-8/0001856725-26-000007","accession_number":"0001856725-26-000007","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"3","title":"3 — Rani Therapeutics Holdings, Inc. — 2026-07-08","url_slug":"/sec/cik-0001856725/3/0001871423-26-000008","accession_number":"0001871423-26-000008","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Rani Therapeutics Holdings, Inc. — 2026-06-30","url_slug":"/sec/cik-0001856725/8-k/0001856725-26-000003","accession_number":"0001856725-26-000003","importance":35},{"ts":"2026-06-27","kind":"sec.insider.f","reporter":"Imran Talat","title":"Chief Executive Officer","shares":7927,"price_per_share":0.74,"usd_value":5866,"security_title":"Class A Common Stock","importance":15.00586598},{"ts":"2026-06-27","kind":"sec.insider.309","reporter":"Javadi Alireza","title":"Chief Technical Officer","shares":309,"price_per_share":0.74,"usd_value":229,"security_title":"Class A Common Stock","importance":15.00022866},{"ts":"2026-06-27","kind":"sec.insider.f","reporter":"Javadi Alireza","title":"Chief Technical Officer","shares":309,"price_per_share":0.74,"usd_value":229,"security_title":"Class A Common Stock","importance":15.00022866},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-06-05","url_slug":"/sec/cik-0001856725/4/0001869579-26-000003","accession_number":"0001869579-26-000003","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-06-05","url_slug":"/sec/cik-0001856725/4/0001979211-26-000003","accession_number":"0001979211-26-000003","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-06-05","url_slug":"/sec/cik-0001856725/4/0002123843-26-000005","accession_number":"0002123843-26-000005","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-06-01","url_slug":"/sec/cik-0001856725/4/0001864485-26-000003","accession_number":"0001864485-26-000003","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-06-01","url_slug":"/sec/cik-0001856725/4/0001902958-26-000004","accession_number":"0001902958-26-000004","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Rani Therapeutics Holdings, Inc. — 2026-06-01","url_slug":"/sec/cik-0001856725/4/0002094741-26-000004","accession_number":"0002094741-26-000004","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Rani Therapeutics Holdings, Inc. — 2026-05-15","url_slug":"/sec/cik-0001856725/10-q/0001193125-26-226703","accession_number":"0001193125-26-226703","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Rani Therapeutics Holdings, Inc. — 2026-05-15","url_slug":"/sec/cik-0001856725/8-k/0001193125-26-226691","accession_number":"0001193125-26-226691","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Rani Therapeutics Holdings, Inc. — 2026-05-15","url_slug":"/sec/cik-0001856725/schedule-13g-a/0002006045-26-000008","accession_number":"0002006045-26-000008","importance":30}]}